Medication info
Dapagliflozin 5mg Tablets (Dapagliflozin Propanediol Hydrate)

Dapagliflozin 5mg Tablets (Dapagliflozin Propanediol Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›6.15mg / 1 tablet
Manufacturer / importer
Aju Pharmaceutical Co., Ltd.
Appearance
Yellow, biconvex, round film-coated tablet
Packaging
PTP - 28 tablets/box [7 tablets/PTP x 4]
Approval status
Active

MFDS item code 202203843 · Approved 2022.10.17 · Insurance code 654005990

Summary

Main use
Improvement of glycemic control in type 2 diabetes; prevention of worsening of chronic heart failure and chronic kidney disease
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10 mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, the recommended initial dose of this drug when administered in combination with metformin is 5 mg once daily or 10 mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this drug is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this drug to improve glycemic control is not recommended. - eGFR less than 25 mL/min/1.73m2: Initiation of this drug is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Aju Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes; prevention of worsening of chronic heart failure and chronic kidney disease

  • Type 2 diabetes
  • poor blood sugar control
  • cardiovascular diseases
  • cardiovascular risk factors
  • chronic heart failure
  • heart failure
  • chronic kidney disease
  • decreased glomerular filtration rate
  • end-stage kidney disease
View approved original text

This medication helps control blood sugar levels in patients with type 2 diabetes and reduces the risk of death and hospitalization due to cardiovascular disease in patients with chronic heart failure. It is also used to decrease the risk of deterioration in kidney function in patients with chronic kidney disease. Take this medication in conjunction with standard therapies for each condition to enhance effectiveness. This treatment aims to improve the health status of patients.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10 mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, the recommended initial dose of this drug when administered in combination with metformin is 5 mg once daily or 10 mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this drug is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this drug to improve glycemic control is not recommended. - eGFR less than 25 mL/min/1.73m2: Initiation of this drug is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be used in patients with a history of allergic reactions, those with type 1 diabetes, or individuals with certain genetic lactose intolerance disorders. It is particularly contraindicated in patients undergoing dialysis. Patients with reduced fluid volume or impaired kidney function must use this medication with caution. This drug may lower blood pressure and affect kidney function, so fluid status and kidney function should be monitored closely before and during treatment. The most commonly reported side effect in clinical trials is genital infections, which may occur more frequently in women. Other possible symptoms include hypoglycemia, dehydration, dry mouth, dizziness, and urinary tract infections. This medication can cause serious metabolic disturbances known as diabetic ketoacidosis; if relevant symptoms or signs occur, consult a healthcare professional immediately. Elderly patients or those taking diuretics are at a higher risk of dehydration and hypotension and should be monitored more closely. Pregnant women or nursing mothers are advised against using this medication, and it should be discontinued if pregnancy is confirmed. This drug may increase the risk of hypoglycemia when used in conjunction with insulin or sulfonylureas, thus dosage adjustments for these medications may be necessary. During treatment, it is important to regularly check blood sugar control status as well as fluid status and kidney function periodically. This medication has not been confirmed for safety and efficacy in children and should not be used in this population. In case of overdose, there is no specific antidote, and appropriate treatment should be provided based on symptoms. Finally, caution should be exercised during driving or operating machinery due to possible side effects such as hypoglycemia.

Side effects

Vulvitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, lumbar pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, increased hematocrit, decreased serum creatinine clearance at the beginning of treatment, dyslipidemia, increased serum creatinine at the beginning of treatment, elevated blood urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral arterial occlusion, angina pectoris, myocardial infarction, choledocholithiasis, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, sensory disturbances, cerebral infarction, nerve compression, urinary sepsis, acute kidney injury, renal impairment, chest pain, chest discomfort, fatigue, edema, foreign body sensation, facial edema, facial pain, warmth, flu-like symptoms, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, irregular menstruation, hair loss, dermatitis, dry skin, allergic dermatitis, contact dermatitis, diabetic foot ulcer, hyperhidrosis eczema, dyshidrosis, eczema, hyperkeratosis, nail pigmentation, skin lesions, urticaria, cold sweat, flank pain, fibromyalgia, limb discomfort, muscle cramps, musculoskeletal discomfort, osteopenia, muscle weakness, ligament sprain, dry eye, eye pain, retinal disorders, visual impairment, blepharitis, cataract, conjunctival edema, allergic conjunctivitis, conjunctivitis, diplopia, eyelid edema, keratitis, glaucoma, visual impairment, floaters, oropharyngeal pain, allergic rhinitis, asthma, vocal disorders, epistaxis, sleep apnea syndrome, wheezing, atherosclerosis, flushing, peripheral coldness, varicose veins, vascular headache, orthostatic hypotension, atrial fibrillation, diastolic dysfunction, palpitations, anxiety disorder, enuresis, auditory hallucinations, sleep disorders, insomnia, fatty liver, gallbladder polyp, vertigo, tinnitus, urgency, diabetic nephropathy, overactive bladder, microalbuminuria, stress urinary incontinence, hesitancy, urinary stones, abnormal urination, elevated blood lactate levels, lymphopenia, vitamin D deficiency, decreased appetite, thirst, increased appetite, headache, decreased sensation, nasopharyngitis, upper respiratory infection, asthenia, hunger, vaginal discharge, pruritus, arthralgia, musculoskeletal pain, limb pain, myalgia, osteoarthritis, diabetic retinopathy, cough, dyspnea, palpitations, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. The recommended storage temperature is room temperature between 1 degree and 30 degrees Celsius. This helps maintain the drug's effectiveness and safety.

Appearance and packaging

Appearance

Yellow, biconvex, round film-coated tablet

Package unit

PTP - 28 tablets/box [7 tablets/PTP x 4]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.